期刊文献+

溴隐亭联合大剂量维生素B_6治疗高泌乳血症疗效观察 被引量:8

Effect of Bromocriptine combined with large doses of vitamin B_6 in treatment of hyperprolactinemia
下载PDF
导出
摘要 目的:探讨溴隐亭联合大剂量维生素B6在高泌乳血症治疗中的作用。方法:门诊高泌乳血症患者163例,随机分为两组,观察组82例,服用溴隐亭和维生素B6,对照组81例,服用溴隐亭,于服药后的1、2、3、4、5、6个月测定血清PRL。结果:治疗前两组血清PRL水平无明显差异(P>0.05)。治疗6个月后,观察组血清PRL明显低于对照组(P<0.01)。观察组有75例血清PRL正常,占91.46%,68例停药,占82.92%;对照组有64例血清PRL正常,占79.01%,有41例停药,占50.61%。观察组中无恶心呕吐副作用出现,对照组中有8例出现恶心呕吐症状;治疗组1例因不能坚持服药,血清PRL出现反弹现象,对照组2例。停服溴隐亭1个月后观察组无复发,对照组有2例复发。结论:溴隐亭联合大剂量维生素B6治疗高泌乳血症可以缩短疗程,减少溴隐亭用量,降低药物副作用。 Objective: To explore the role of Bromocriptine combined with large doses of VitB6 in treatment of hyperprolactinemia.Methods: 163 cases with hyperprolactinemia were randomly divided into two groups,the observation group of 82 cases,took Bromocriptine and vitamin B6,the control group of 81 cases,took Bromocriptine,serum PRL after treatment 1,2,3,4,5,6 months.Results: Both groups had no significant difference in serum PRL before treatment(P〉0.05),the serum PRL levels of observation group was significantly lower than that of the control group after treatment 6 months(P〈0.01).Observation group,75 patients with serum PRL was normal,accounting for 91.46%,with 68 cases of withdrawal,82.92%;in the control group,64 cases of normal serum PRL,accounting for 79.01%,with 41 cases of withdrawal,accounting for 50.61%.Observation group had no side effects of nausea and vomiting,in control group,8 cases showed symptoms of nausea and vomiting;1 case of observed group,2 cases of control group,because they could not insist on taking the drug serum PRL rebound phenomenon.Stop taking Bromocriptine 6 months later,the observation group had no recurrence,recurrence in the control group with 2 cases.Conclusion: Bromocriptine combined with large doses of vitamin VitB6 in treatment of hyperprolactinemia can shorten the course of treatment,reduce the dosage of Bromocriptine,reduce side effects.
作者 谭庆玲
出处 《中国医药导报》 CAS 2011年第11期69-70,共2页 China Medical Herald
关键词 高泌乳素血症 泌乳素 溴隐亭 维生素B6 Hyperprolactinemia PRL Bromocriptine VitB6
  • 相关文献

参考文献4

二级参考文献23

  • 1杨卉,林其德.高催乳素血症的研究进展[J].国外医学(计划生育分册),2004,23(3):147-150. 被引量:22
  • 2盛燕.高催乳素血症的药物治疗[J].实用妇产科杂志,2007,23(2):71-73. 被引量:19
  • 3杨业洲.高催乳素血症生育过程的管理[J].实用妇产科杂志,2007,23(2):75-77. 被引量:4
  • 4Biller BM, Luciano A, Crosignani PG,et al. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med, 1999, 44[12 Suppl]:1075-1084.
  • 5Andrews ZB, Grattan DR. Opioid receptor subtypes involved in the regulation of prolactin secretion during pregnancy and lactation. J Neuroendocrinol, 2003, 15(3):227-236.
  • 6Phelps JY, Bugg EM, Shamblott MJ, et al. Prolaction gene expression in human ovarian follicular cells. Fertil Steril, 2003, 79(1):182-185.
  • 7Vera-Lastra O, Luis J, Luis R, et al. Prolactin and autoimmun. Autoimmun Rev, 2002, 1:360-364.
  • 8Serri O, Chik CL, Ur E, et al, Diagnosis and management of hyperprolactinemia. CMAJ, 2003, 169(6):575-581.
  • 9Emiliano AB, Fudge JL, From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions. Neuropsychopharmacology, 2004, 29(5):833-846.
  • 10Gurlek A, Nar A, Gedik O. Isolated adrenocorticotropic hormone deficiency, thyroid autoimmunity, and transient hyperprolactinemia. Endocr Pract, 2001, 7(2):102-105.

共引文献28

同被引文献85

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部